Articles from Oxford Finance LLC

Oxford Finance LLC (“Oxford”), a leading specialty finance firm, is pleased to announce its Healthcare Real Estate and Asset-Based Lending (ABL) team closed 10 transactions with new loan commitments of over $715 million during the first half of 2025. This achievement underscores Oxford's commitment to providing innovative and flexible financing solutions to the healthcare industry. The team’s success in the first half of 2025 highlights its ability to adapt to market demands and provide comprehensive support to healthcare operators seeking growth opportunities.

Oxford Finance LLC (“Oxford” or the “Company”) today announced its Board of Managers has appointed Timothy A. Lex as President and Chief Executive Officer. J. Alden Philbrick, IV, who founded the company and has served as the Company’s Chief Executive Officer since inception, will assume the role of Executive Chairman and continue as Chairman of the board.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences, healthcare services, healthtech, business services and SaaS companies worldwide, is pleased to announce the appointment of David Hickman and Garrett Henn as Co-Heads of Oxford’s enterprise lending division, which includes life sciences, healthtech, and SaaS.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare companies worldwide, is pleased to announce that its Healthcare Real Estate and ABL Group continued its stable growth in 2023, with Oxford providing over $430 million of capital commitments. The group closed a total of 11 transactions ranging in size from $2.0 million to $89.0 million.

Oxford Finance LLC (“Oxford”), a leading specialty firm that provides senior debt to life sciences and healthcare companies worldwide is pleased to announce that its Healthcare Real Estate Group closed a strong first half of 2023, providing total capital commitments of approximately $200 million in six transactions.

Oxford Finance (“Oxford”), a leading specialty finance firm providing senior debt to healthcare and life sciences companies worldwide, is pleased to announce the closing of a $105 million senior debt facility with Headspace (“the Company”), a pioneering digital healthcare company.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm providing senior debt to healthcare and life sciences companies worldwide, is pleased to announce it recently provided a $42 million senior debt facility to Amino Health (“Amino”), a rapidly growing digital health company.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, is pleased to announce that its Healthcare Leveraged Lending Group closed a strong first half of 2023, providing approximately $1 billion of commitments across 13 new platform investments and supporting multiple follow-on investments by portfolio companies.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, is pleased to announce that its Healthcare Real Estate Group closed a record level of originations in 2022, with Oxford providing over $867 million of capital commitments. The group closed a total of 14 transactions, with credit facilities ranging from $9 million to over $124 million.

Oxford Finance LLC ("Oxford"), a leading specialty finance firm focused on healthcare services and life sciences companies worldwide, today announced the closing of a $115 million senior credit facility to Pearl Street Dental Partners ("Pearl Street" or "the Company"), a fast-growing dental platform owned by SkyKnight Capital ("SkyKnight"), dentists, and management.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, is pleased to announce that their Healthcare Real Estate Group closed over $347 million of transactions during Q2 & Q3 of 2022, bringing the total commitments YTD to over $636 million.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm providing senior debt to healthcare services and life sciences companies worldwide, today announced the closing of a $124.75 million senior credit facility for the acquisition of four Autumn Lake Healthcare Skilled Nursing Facilities (“Autumn Lake” or “the Company”) located in Maryland containing 520 licensed beds.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, is announcing the closing of a $30 million senior secured term loan with Selux Diagnostic, Inc. (“Selux” or “the Company”), a Boston-based medical device company leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm focused on healthcare services and life sciences companies worldwide, today announced the closing of a $660 million senior credit facility to Specialty Dental Brands (“SDB” or “the Company”), a dental services organization focused on pediatric dentistry, orthodontics, and oral surgery. Oxford acted as the sole bookrunner and administrative agent on the transaction.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, is pleased to announce that Rohit Gandhi, a seasoned investment professional, has joined Oxford as a senior director.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, today announced the closing of a $400 million senior unsecured note offering by Oxford and Oxford Finance Co-Issuer II Inc., a wholly owned subsidiary of Oxford. The notes bear interest at a fixed rate of 6.375% and mature in 2027. Oxford intends to use the net proceeds of this offering to redeem its $300 million 6.375% Senior Notes due 2022 and repay a portion of its funding debt.

Oxford Finance LLC (“Oxford”) is a leading provider of capital for growth and development to life sciences and healthcare services companies worldwide. We are pleased to announce our Healthcare Leveraged Lending Group has built on its 2020 new business record by closing on more than $1.4 billion of capital commitments in 2021, including over $700 million closed in the 4th quarter of the year. The Group invested in 20 new platform companies and upsized the debt facilities for seven (7) portfolio companies to support M&A growth.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, has announced the closing of a $50 million senior secured term loan with Kezar Life Sciences, Inc. (NASDAQ: KZR) (“Kezar” or “the Company”), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders.

Oxford Finance LLC ("Oxford"), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, has announced the closing of a $20 million senior secured term loan with PlateletBio (or "the Company"), a preclinical-stage biotechnology company pioneering an entirely new platform of allogeneic cell therapies based on platelet biology.

Oxford Finance LLC ("Oxford"), a leading specialty finance firm focused on healthcare services and life sciences companies worldwide, today announced the closing of a senior credit facility and revolving line of credit to Endodontic Practice Partners ("EPP" or "the Company"), a River Cities Capital ("River Cities") portfolio company.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm providing senior debt to healthcare services and life sciences companies worldwide, is pleased to announce that Kevin Harbour has joined Oxford’s healthcare services real estate and asset-based lending team.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm providing senior debt to healthcare services and life sciences companies worldwide, today announced the closing of a $28 million senior credit facility to AvantGarde Senior Living (“AvantGarde” or “the Company”), A Luxurious Senior Living Community™. The funds are being used to refinance existing debt on one facility located in Tarzana, California.

Oxford Finance LLC ("Oxford"), a leading specialty finance firm focused on healthcare services and life sciences companies worldwide, today announced the closing of a senior credit facility and revolving line of credit to Paradigm Health ("Paradigm" or "the Company"), a leading provider of hospice and palliative care in the state of Indiana.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm providing senior debt to healthcare services and life sciences companies worldwide, today announced the closing of a $27.5 million senior credit facility to Cascades Healthcare (“Cascades” or “the Company”), an owner and operator of long term care facilities. The funds were used for the acquisition of four skilled nursing facilities (“SNFs”) located in Texas containing 647 licensed beds.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm providing senior debt to healthcare services and life sciences companies worldwide, today announced the closing of a $24 million senior credit facility with Lantern Group (“Lantern” or “the Company”), an owner and operator of skilled nursing and assisted living facilities. The funds were used to acquire three assisted living and memory care facilities located in Ohio, Lantern of Chagrin, Lantern of Madison, and Lantern of Saybrook.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, has announced the closing of a $125 million senior secured term loan with Kala Pharmaceuticals, Inc. (NASDAQ: KALA) (“Kala” or “the Company”), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, is pleased to announce David Hickman’s new position as managing director of business development in Oxford’s life sciences division. David has been appointed to Debbie Baker’s position; she will be retiring on June 30th.

Oxford Finance LLC (“Oxford”), a leading specialty finance firm focused on healthcare services and life sciences companies worldwide, is pleased to announce that Sunil Annapareddy has joined Oxford’s healthcare services leveraged lending team.

Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, has announced the closing of a $50 million senior secured term loan with Mainstay Medical Holdings plc (“Mainstay” or “the Company”), a medical device company focused on commercializing an innovative implantable restorative neurostimulation system, ReActiv8®, for the treatment of disabling mechanical chronic low back pain (“CLBP”).